Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/16/2914212/0/en/Amendment-of-Disclosures-in-Past-Management-Information-Circulars.html
https://www.globenewswire.com/news-release/2024/07/02/2907855/0/en/BetterLife-Announces-Closing-of-a-Private-Placement.html
https://www.globenewswire.com/news-release/2024/06/26/2904446/0/en/BetterLife-To-Present-BETR-001-Preclinical-Data-at-the-2024-Conference-of-the-Federation-of-European-Neuroscience-Societies-FENS-in-Vienna-Austria.html
https://www.globenewswire.com/news-release/2024/05/14/2881308/0/en/BetterLife-Obtains-Excellent-Animal-Cardiopulmonary-Safety-Data-for-Oral-BETR-001.html
https://www.globenewswire.com/news-release/2024/05/03/2875390/0/en/BetterLife-Announces-Intent-to-Complete-Private-Placement-of-Units.html
https://www.globenewswire.com/news-release/2024/05/01/2873186/0/en/BetterLife-Advances-BETR-001-IND-enabling-Studies.html
https://www.globenewswire.com/news-release/2024/04/11/2861439/0/en/BetterLife-To-Present-at-the-2024-Bloom-Burton-Co-Healthcare-Investor-Conference.html
https://www.globenewswire.com/news-release/2024/04/03/2856884/0/en/BetterLife-Announces-Closing-of-1-168-Million-Convertible-Debentures-to-Further-Advance-IND-enabling-Studies-of-its-Non-hallucinogenic-LSD-based-Drug-Candidate-BETR-001.html
https://www.globenewswire.com//news-release/2024/03/04/2839506/0/en/BetterLife-s-2-Bromo-LSD-for-Treatment-of-Depression-Highlighted-by-Carleton-University.html
https://www.globenewswire.com//news-release/2024/01/02/2802635/0/en/BetterLife-Announces-Closing-of-Convertible-Debentures-For-Further-Development-of-BETR-001.html